Diabetic foot infections: A microbiologic review
•Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options.•The appropriateness of a single, empiric regimen for all instances of diabetic foot infections (DFIs) is difficult to determine.•This review analyzes global...
Gespeichert in:
| Veröffentlicht in: | Foot (Edinburgh, Scotland) Scotland), 2022-05, Vol.51, p.101877-101877, Article 101877 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 101877 |
|---|---|
| container_issue | |
| container_start_page | 101877 |
| container_title | Foot (Edinburgh, Scotland) |
| container_volume | 51 |
| creator | Hawkins, Brandon K. Barnard, Marie Barber, Katie E. Stover, Kayla R. Cretella, David A. Wingler, Mary Joyce B. Wagner, Jamie L. |
| description | •Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options.•The appropriateness of a single, empiric regimen for all instances of diabetic foot infections (DFIs) is difficult to determine.•This review analyzes global literature relating to cultures, incidence, risk factors, resistance, and bacterial distribution in DFIs.•S. aureus remains a significant pathogen, with a growing incidence of P. aeruginosa and MDR gram-negative bacilli.•Local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.
Diabetes mellitus continues to be an increasingly common comorbidity. Diabetic foot infections are one of the most common causes of hospitalization in this population, and account for a significant portion of increased hospitalization and healthcare expenditure. Complications, such as osteomyelitis, can necessitate the use of multiple, prolonged antibiotic courses. These courses often consist of broad-spectrum, empiric therapy determined by organisms considered to be commonly associated with these types of infections. Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options. Furthermore, patient specific risk factors can impact the microbiologic diversity found in these infections. As a result, it is difficult to determine if a single empiric regimen is appropriate for all instances of diabetic foot infections.
This review analyzes global literature relating to the culture methods, incidence, risk factors, resistance patterns, and geographic distribution of the microorganisms isolated from diabetic foot infections using the PRISMA statement for systematic review and meta-analysis reporting.
Staphylococcus aureus remains a significant pathogen, with a growing incidence of Pseudomonas aeruginosa and MDR gram-negative bacilli.
Though some individualized risk factors can be useful, local epidemiology and resistance patterns remain essential for antibiotic treatment considerations. |
| doi_str_mv | 10.1016/j.foot.2021.101877 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2655560466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0958259221001036</els_id><sourcerecordid>2655560466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-4ae61c5bdd9ace03ae75a10f522d70bf5905ea257043f839c3d94dc9386877633</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7rr6BzxIj1665qNJG_Ei6ycseNFzSJOpZGmbNekq_ntTunr0NDA88zLvg9A5wUuCibjaLBvvhyXFlIyLqiwP0JxwRnMqBTtEcyx5lVMu6QydxLjBGHNK6TGaMV6IilXlHOE7p2sYnMnGrMz1DZjB-T5eZ7dZ50zwtfOtf09AgE8HX6foqNFthLP9XKC3h_vX1VO-fnl8Xt2uc0NLMuSFBkEMr62V2gBmGkquCW7SA7bEdcMl5qApL3HBmopJw6wsrJGsEqmHYGyBLqfcbfAfO4iD6lw00La6B7-LigrOucCFEAmlE5q-jTFAo7bBdTp8K4LVaEpt1NhOjabUZCodXezzd3UH9u_kV00CbiYAUsvUPKhoHPQGrAvJkbLe_Zf_A9tPeHk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655560466</pqid></control><display><type>article</type><title>Diabetic foot infections: A microbiologic review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hawkins, Brandon K. ; Barnard, Marie ; Barber, Katie E. ; Stover, Kayla R. ; Cretella, David A. ; Wingler, Mary Joyce B. ; Wagner, Jamie L.</creator><creatorcontrib>Hawkins, Brandon K. ; Barnard, Marie ; Barber, Katie E. ; Stover, Kayla R. ; Cretella, David A. ; Wingler, Mary Joyce B. ; Wagner, Jamie L.</creatorcontrib><description>•Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options.•The appropriateness of a single, empiric regimen for all instances of diabetic foot infections (DFIs) is difficult to determine.•This review analyzes global literature relating to cultures, incidence, risk factors, resistance, and bacterial distribution in DFIs.•S. aureus remains a significant pathogen, with a growing incidence of P. aeruginosa and MDR gram-negative bacilli.•Local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.
Diabetes mellitus continues to be an increasingly common comorbidity. Diabetic foot infections are one of the most common causes of hospitalization in this population, and account for a significant portion of increased hospitalization and healthcare expenditure. Complications, such as osteomyelitis, can necessitate the use of multiple, prolonged antibiotic courses. These courses often consist of broad-spectrum, empiric therapy determined by organisms considered to be commonly associated with these types of infections. Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options. Furthermore, patient specific risk factors can impact the microbiologic diversity found in these infections. As a result, it is difficult to determine if a single empiric regimen is appropriate for all instances of diabetic foot infections.
This review analyzes global literature relating to the culture methods, incidence, risk factors, resistance patterns, and geographic distribution of the microorganisms isolated from diabetic foot infections using the PRISMA statement for systematic review and meta-analysis reporting.
Staphylococcus aureus remains a significant pathogen, with a growing incidence of Pseudomonas aeruginosa and MDR gram-negative bacilli.
Though some individualized risk factors can be useful, local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.</description><identifier>ISSN: 0958-2592</identifier><identifier>EISSN: 1532-2963</identifier><identifier>DOI: 10.1016/j.foot.2021.101877</identifier><identifier>PMID: 35468387</identifier><language>eng</language><publisher>Scotland: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotic resistance ; Diabetes Mellitus ; Diabetic Foot - microbiology ; Diabetic foot infections ; Drug Resistance, Microbial ; Epidemiology ; Gram-Negative Bacteria ; Humans ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa ; Staphylococcal Infections - complications ; Staphylococcal Infections - drug therapy ; Staphylococcus aureus</subject><ispartof>Foot (Edinburgh, Scotland), 2022-05, Vol.51, p.101877-101877, Article 101877</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c271t-4ae61c5bdd9ace03ae75a10f522d70bf5905ea257043f839c3d94dc9386877633</citedby><cites>FETCH-LOGICAL-c271t-4ae61c5bdd9ace03ae75a10f522d70bf5905ea257043f839c3d94dc9386877633</cites><orcidid>0000-0003-0781-7438 ; 0000-0001-7735-1130 ; 0000-0002-2037-2616 ; 0000-0002-6006-7894</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0958259221001036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35468387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hawkins, Brandon K.</creatorcontrib><creatorcontrib>Barnard, Marie</creatorcontrib><creatorcontrib>Barber, Katie E.</creatorcontrib><creatorcontrib>Stover, Kayla R.</creatorcontrib><creatorcontrib>Cretella, David A.</creatorcontrib><creatorcontrib>Wingler, Mary Joyce B.</creatorcontrib><creatorcontrib>Wagner, Jamie L.</creatorcontrib><title>Diabetic foot infections: A microbiologic review</title><title>Foot (Edinburgh, Scotland)</title><addtitle>Foot (Edinb)</addtitle><description>•Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options.•The appropriateness of a single, empiric regimen for all instances of diabetic foot infections (DFIs) is difficult to determine.•This review analyzes global literature relating to cultures, incidence, risk factors, resistance, and bacterial distribution in DFIs.•S. aureus remains a significant pathogen, with a growing incidence of P. aeruginosa and MDR gram-negative bacilli.•Local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.
Diabetes mellitus continues to be an increasingly common comorbidity. Diabetic foot infections are one of the most common causes of hospitalization in this population, and account for a significant portion of increased hospitalization and healthcare expenditure. Complications, such as osteomyelitis, can necessitate the use of multiple, prolonged antibiotic courses. These courses often consist of broad-spectrum, empiric therapy determined by organisms considered to be commonly associated with these types of infections. Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options. Furthermore, patient specific risk factors can impact the microbiologic diversity found in these infections. As a result, it is difficult to determine if a single empiric regimen is appropriate for all instances of diabetic foot infections.
This review analyzes global literature relating to the culture methods, incidence, risk factors, resistance patterns, and geographic distribution of the microorganisms isolated from diabetic foot infections using the PRISMA statement for systematic review and meta-analysis reporting.
Staphylococcus aureus remains a significant pathogen, with a growing incidence of Pseudomonas aeruginosa and MDR gram-negative bacilli.
Though some individualized risk factors can be useful, local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic resistance</subject><subject>Diabetes Mellitus</subject><subject>Diabetic Foot - microbiology</subject><subject>Diabetic foot infections</subject><subject>Drug Resistance, Microbial</subject><subject>Epidemiology</subject><subject>Gram-Negative Bacteria</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Pseudomonas aeruginosa</subject><subject>Staphylococcal Infections - complications</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcus aureus</subject><issn>0958-2592</issn><issn>1532-2963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7rr6BzxIj1665qNJG_Ei6ycseNFzSJOpZGmbNekq_ntTunr0NDA88zLvg9A5wUuCibjaLBvvhyXFlIyLqiwP0JxwRnMqBTtEcyx5lVMu6QydxLjBGHNK6TGaMV6IilXlHOE7p2sYnMnGrMz1DZjB-T5eZ7dZ50zwtfOtf09AgE8HX6foqNFthLP9XKC3h_vX1VO-fnl8Xt2uc0NLMuSFBkEMr62V2gBmGkquCW7SA7bEdcMl5qApL3HBmopJw6wsrJGsEqmHYGyBLqfcbfAfO4iD6lw00La6B7-LigrOucCFEAmlE5q-jTFAo7bBdTp8K4LVaEpt1NhOjabUZCodXezzd3UH9u_kV00CbiYAUsvUPKhoHPQGrAvJkbLe_Zf_A9tPeHk</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Hawkins, Brandon K.</creator><creator>Barnard, Marie</creator><creator>Barber, Katie E.</creator><creator>Stover, Kayla R.</creator><creator>Cretella, David A.</creator><creator>Wingler, Mary Joyce B.</creator><creator>Wagner, Jamie L.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0781-7438</orcidid><orcidid>https://orcid.org/0000-0001-7735-1130</orcidid><orcidid>https://orcid.org/0000-0002-2037-2616</orcidid><orcidid>https://orcid.org/0000-0002-6006-7894</orcidid></search><sort><creationdate>202205</creationdate><title>Diabetic foot infections: A microbiologic review</title><author>Hawkins, Brandon K. ; Barnard, Marie ; Barber, Katie E. ; Stover, Kayla R. ; Cretella, David A. ; Wingler, Mary Joyce B. ; Wagner, Jamie L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-4ae61c5bdd9ace03ae75a10f522d70bf5905ea257043f839c3d94dc9386877633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic resistance</topic><topic>Diabetes Mellitus</topic><topic>Diabetic Foot - microbiology</topic><topic>Diabetic foot infections</topic><topic>Drug Resistance, Microbial</topic><topic>Epidemiology</topic><topic>Gram-Negative Bacteria</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Pseudomonas aeruginosa</topic><topic>Staphylococcal Infections - complications</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hawkins, Brandon K.</creatorcontrib><creatorcontrib>Barnard, Marie</creatorcontrib><creatorcontrib>Barber, Katie E.</creatorcontrib><creatorcontrib>Stover, Kayla R.</creatorcontrib><creatorcontrib>Cretella, David A.</creatorcontrib><creatorcontrib>Wingler, Mary Joyce B.</creatorcontrib><creatorcontrib>Wagner, Jamie L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Foot (Edinburgh, Scotland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hawkins, Brandon K.</au><au>Barnard, Marie</au><au>Barber, Katie E.</au><au>Stover, Kayla R.</au><au>Cretella, David A.</au><au>Wingler, Mary Joyce B.</au><au>Wagner, Jamie L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetic foot infections: A microbiologic review</atitle><jtitle>Foot (Edinburgh, Scotland)</jtitle><addtitle>Foot (Edinb)</addtitle><date>2022-05</date><risdate>2022</risdate><volume>51</volume><spage>101877</spage><epage>101877</epage><pages>101877-101877</pages><artnum>101877</artnum><issn>0958-2592</issn><eissn>1532-2963</eissn><abstract>•Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options.•The appropriateness of a single, empiric regimen for all instances of diabetic foot infections (DFIs) is difficult to determine.•This review analyzes global literature relating to cultures, incidence, risk factors, resistance, and bacterial distribution in DFIs.•S. aureus remains a significant pathogen, with a growing incidence of P. aeruginosa and MDR gram-negative bacilli.•Local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.
Diabetes mellitus continues to be an increasingly common comorbidity. Diabetic foot infections are one of the most common causes of hospitalization in this population, and account for a significant portion of increased hospitalization and healthcare expenditure. Complications, such as osteomyelitis, can necessitate the use of multiple, prolonged antibiotic courses. These courses often consist of broad-spectrum, empiric therapy determined by organisms considered to be commonly associated with these types of infections. Extended periods of broad-spectrum antibiotic regimens can contribute to antibiotic resistance and ultimately limit future treatment options. Furthermore, patient specific risk factors can impact the microbiologic diversity found in these infections. As a result, it is difficult to determine if a single empiric regimen is appropriate for all instances of diabetic foot infections.
This review analyzes global literature relating to the culture methods, incidence, risk factors, resistance patterns, and geographic distribution of the microorganisms isolated from diabetic foot infections using the PRISMA statement for systematic review and meta-analysis reporting.
Staphylococcus aureus remains a significant pathogen, with a growing incidence of Pseudomonas aeruginosa and MDR gram-negative bacilli.
Though some individualized risk factors can be useful, local epidemiology and resistance patterns remain essential for antibiotic treatment considerations.</abstract><cop>Scotland</cop><pub>Elsevier Ltd</pub><pmid>35468387</pmid><doi>10.1016/j.foot.2021.101877</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0781-7438</orcidid><orcidid>https://orcid.org/0000-0001-7735-1130</orcidid><orcidid>https://orcid.org/0000-0002-2037-2616</orcidid><orcidid>https://orcid.org/0000-0002-6006-7894</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0958-2592 |
| ispartof | Foot (Edinburgh, Scotland), 2022-05, Vol.51, p.101877-101877, Article 101877 |
| issn | 0958-2592 1532-2963 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2655560466 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anti-Bacterial Agents - therapeutic use Antibiotic resistance Diabetes Mellitus Diabetic Foot - microbiology Diabetic foot infections Drug Resistance, Microbial Epidemiology Gram-Negative Bacteria Humans Microbial Sensitivity Tests Pseudomonas aeruginosa Staphylococcal Infections - complications Staphylococcal Infections - drug therapy Staphylococcus aureus |
| title | Diabetic foot infections: A microbiologic review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A18%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetic%20foot%20infections:%20A%20microbiologic%20review&rft.jtitle=Foot%20(Edinburgh,%20Scotland)&rft.au=Hawkins,%20Brandon%20K.&rft.date=2022-05&rft.volume=51&rft.spage=101877&rft.epage=101877&rft.pages=101877-101877&rft.artnum=101877&rft.issn=0958-2592&rft.eissn=1532-2963&rft_id=info:doi/10.1016/j.foot.2021.101877&rft_dat=%3Cproquest_cross%3E2655560466%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655560466&rft_id=info:pmid/35468387&rft_els_id=S0958259221001036&rfr_iscdi=true |